Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-31 Sale |
2024-08-02 4:02 pm |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Consultant |
240 | $0.1763 | $42 | 0 (Direct) |
View |
| 2024-02-21 Purchase |
2024-02-22 1:38 pm |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
37,500 | $0.39 | $14,625 | 38,258 (Direct) |
View |
| 2024-02-20 Purchase |
2024-02-21 2:58 pm |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
41,600 | $0.3587 | $14,922 | 43,959 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-11 Expired |
2025-02-03 08:49 am |
2020-01-12 2025-01-11 |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
2 | $0 | 975 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:28 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager |
1,500 | $0 | 3,900 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:26 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | Jagpal Netta Chief Financial Officer |
3,750 | $0 | 6,250 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:25 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director |
550 | $0 | 975 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:24 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer |
3,750 | $0 | 7,505 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:22 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | Grove Janet P Director |
550 | $0 | 975 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:21 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
2,750 | $0 | 5,350 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:20 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
6,250 | $0 | 14,300 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:18 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director |
550 | $0 | 975 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 09:17 am |
N/A 2029-12-19 |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
550 | $0 | 977 (Direct) |
View |
| 2024-05-27 Expired |
2024-05-28 4:27 pm |
2019-05-27 2024-05-27 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer |
394 | $0 | 75,100 (Direct) |
View |
| 2024-05-27 Expired |
2024-05-28 4:26 pm |
2019-05-27 2024-05-27 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
545 | $0 | 52,000 (Direct) |
View |
| 2024-05-27 Expired |
2024-05-28 4:26 pm |
2019-05-27 2024-05-27 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
1,139 | $0 | 161,000 (Direct) |
View |
| 2024-05-27 Expired |
2024-05-28 4:26 pm |
2019-05-27 2024-05-27 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
485 | $0 | 52,000 (Direct) |
View |
| 2024-01-14 Expired |
2024-03-05 3:20 pm |
2019-01-14 2024-01-14 |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
42 | $0 | 8,542 (Direct) |
View |
| 2024-03-04 Expired |
2024-03-05 3:20 pm |
2019-03-04 2024-03-04 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
309 | $0 | 52,545 (Direct) |
View |
| 2024-01-21 Expired |
2024-03-05 3:20 pm |
2019-01-21 2024-01-21 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
121 | $0 | 52,485 (Direct) |
View |
Ownership |
2024-02-27 3:27 pm |
2024-02-20 2029-02-19 |
InMed Pharmaceuticals Inc. | INM | Jagpal Netta Chief Financial Officer |
0 | $0 | 50,000 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:09 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager |
40,000 | $0 | 48,000 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:09 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director |
7,100 | $0 | 8,500 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:09 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer |
65,000 | $0 | 75,494 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:08 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | Tegge Jonathan Interim CFO |
30,000 | $0 | 31,400 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:08 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | Grove Janet P Director |
7,100 | $0 | 8,500 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:07 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
45,000 | $0 | 52,854 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:07 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
136,000 | $0 | 162,139 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:05 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director |
7,100 | $0 | 8,500 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:04 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
45,000 | $0 | 52,606 (Direct) |
View |
| 2023-12-23 Option Award |
2023-12-26 1:04 pm |
N/A 2028-12-22 |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
7,100 | $0 | 8,584 (Direct) |
View |
| 2023-12-05 Expired |
2023-12-06 09:02 am |
2018-12-05 2023-12-05 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer |
848 | $0 | 10,494 (Direct) |
View |
| 2023-08-31 Expired |
2023-08-31 5:22 pm |
2018-08-31 2023-08-31 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
327 | $0 | 7,854 (Direct) |
View |
| 2023-05-16 Expired |
2023-05-16 6:00 pm |
2018-05-16 2023-05-16 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
152 | $0 | 8,181 (Direct) |
View |
| 2023-05-16 Expired |
2023-05-16 5:59 pm |
2018-05-16 2023-05-16 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
485 | $0 | 7,606 (Direct) |
View |
| 2023-05-16 Expired |
2023-05-16 5:58 pm |
2018-05-16 2023-05-16 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
1,818 | $0 | 26,139 (Direct) |
View |
| 2023-03-08 Expired |
2023-03-09 3:47 pm |
2018-03-08 2023-03-08 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
61 | $0 | 8,091 (Direct) |
View |
| 2023-03-08 Expired |
2023-03-09 3:45 pm |
2018-03-08 2023-03-08 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
545 | $0 | 8,333 (Direct) |
View |
| 2023-03-08 Expired |
2023-03-09 3:43 pm |
2018-03-08 2023-03-08 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
545 | $0 | 27,957 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 5:08 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director |
840 | $0 | 1,400 (Direct) |
View |